Founded in 1998, it is a well-known Ejiao brand and listed company, focusing on the pharmaceutical/wine industry, mainly promoting Ejiao-based glue series products and antiviral oral liquid led by antiviral products
Founded in 1998, Furen Pharmaceutical Group is a comprehensive group company dominated by the pharmaceutical and liquor industries, integrating R&D, production, operation, investment and management.
The system includes Henan Furentang Pharmaceutical Co., Ltd., Henan Furen Huaiqingtang Pharmaceutical Co., Ltd., Kaifeng Pharmaceutical (Group) Co., Ltd., Kaifeng Yugang Pharmaceutical Co., Ltd., Henan Tongyuan Pharmaceutical Co., Ltd., Furen Pharmaceutical Technology Development Co., Ltd., Furen Pharmaceutical Group Pharmaceutical Co., Ltd., Furen Pharmaceutical Group Xidelong Tumor Drug Co., Ltd., Beijing Yuance Pharmaceutical Co., Ltd., Beijing Furen Ruihui Biomedical Research Institute, Shanghai Furen Pharmaceutical R&D Co., Ltd., Henan Songhe Liquor Co., Ltd. and the listed company Furen Pharmaceutical Group Industrial Co., Ltd. and many other wholly-owned and holding subsidiaries. The products cover many categories such as Chinese and Western medicine preparations, biochemical pharmaceuticals, biopharmaceuticals, APIs, health foods, etc. In 2005, with the successful listing of Henan Furentang Pharmaceutical Co., Ltd., the power of capital not only pushed Furen to a period of rapid development, but also gradually improved its industry status: in the 2016 list of China's top 100 pharmaceutical industries, Furen Pharmaceutical Group ranked 17th with its strong comprehensive strength.
The early development strategy of "variety as the core, mergers and acquisitions as the main line" finally allowed Furen's production capacity and product line to develop rapidly in a short period of time. So far, Furen has more than 20 dosage forms and more than 1,000 varieties, such as water injection, lyophilized powder injection, and oral solid preparation. The comprehensive production capacity of preparations ranks among the best in the national pharmaceutical industry. In the 2017 new version of the medical insurance catalog, a total of 578 varieties were selected by Furen Group, an increase of 165 varieties compared with the 2009 version of the catalog, an increase of 39.95%, of which 364 were selected in category A, an increase of 42.754%, and 214 varieties were selected in category B, an increase of 35.44%. It has become one of the pharmaceutical companies with more varieties in the country. The trademark "Furen" was recognized as a well-known trademark in China.
With the corporate mission of "People's Medicine, Furen Manufacturing", Furen quickly put forward the business guiding ideology of "profit-oriented and scale-support" in combination with the new market environment, practiced the marketing rule of "focusing on categories and single-point breakthroughs", and launched the precise appeal of the industry expert image of "Furen Pharmaceutical - a professional manufacturer of antiviral drugs", and protected the health of the people and cared for a long life with 39 varieties of antiviral drugs.
At the same time of mergers and acquisitions, Furen has invested heavily in strengthening the construction of enterprise innovation platforms and actively building a first-class innovation team. In 2003, Furen Pharmaceutical Technology Development Co., Ltd. was formally established; In 2006, Furen Technology Center was jointly approved by the National Development and Reform Commission and other five ministries and commissions as a "National Recognized Enterprise Technology Center", and at the same time, the Ministry of Personnel approved the establishment of a postdoctoral research center station. In 2007, it was approved by the Henan Provincial Department of Science and Technology to establish the Henan Provincial Engineering Technology Research Center for the Preparation of Traditional Chinese Medicine Drugs; In 2011, it cooperated with Zhengzhou University to establish a national key laboratory; In 2012, it was awarded the "Top Ten Scientific and Technological Innovation Leading Enterprises in Henan Province"; In 2014, Furen Innovation and Technology Park was established in Zhengzhou New District. At the same time, Furen has also established its own medical research institutes in Beijing and Shanghai. In June 2013, with the addition of Beijing Furen Ruihui Biomedical Research Institute Co., Ltd. and Shanghai Furen Pharmaceutical R&D Co., Ltd. in 2015, Furen pushed its own pharmaceutical R&D sector to a new height.
